Welcome to our dedicated page for NITTO DENKO UNSP/ADR news (Ticker: NDEKY), a resource for investors and traders seeking the latest updates and insights on NITTO DENKO UNSP/ADR stock.
Nitto Denko Corporation (NDEKY) is a leading materials manufacturer founded in 1918 in Japan. With over 13,500 industrial products in various sectors like electronics, automobiles, ecology, and life science, Nitto Denko is dedicated to customer-centric innovation.
Nitto Denko Avecia Inc., a division of Nitto Denko, is a renowned leader in the development and manufacturing services of oligonucleotide therapeutics. Their facilities in Milford, MA, and Cincinnati, OH, along with Nitto Avecia Pharma Services in Irvine, CA, cater to preclinical and commercial needs. With a track record of over 1,200 oligonucleotide sequences, an extensive late-phase portfolio, and a unique end-to-end oligonucleotide solution, Nitto Denko Avecia Inc. continues to set industry standards.
Recently, Nitto Denko Avecia Inc. announced the appointment of Tammy Cooper as President, effective June 21, 2024. Cooper brings 19 years of experience in various roles within the pharmaceutical industry and has played a pivotal role in Nitto Avecia's recent growth. She aims to lead the company to new heights of success through a culture of innovation.
Nitto Denko Corporation has announced its acquisition of Bend Labs, Inc., effective June 1, 2022, with Bend merging into Nitto as Nitto Bend Technologies. This strategic acquisition aims to leverage Bend's advanced sensor technology to enhance Nitto's three focus domains: Information Interface, Next-generation Mobility, and Human Life. The flexible sensors developed by Bend offer high accuracy and durability, making them suitable for applications in automotive automation and digital healthcare. Nitto expects this acquisition to spur innovation and create new businesses utilizing sensor data.